Quantbot Technologies’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,860
Closed -$98.2K 1668
2025
Q4
$98.2K Buy
+9,860
New +$94.2K ﹤0.01% 1418
2025
Q1
Sell
-600
Closed -$5.71K 1435
2024
Q4
$5.71K Buy
+600
New +$6.07K ﹤0.01% 1394
2024
Q2
Sell
-16,721
Closed -$192K 1393
2024
Q1
$192K Sell
16,721
-15,867
-49% -$135K 0.01% 1015
2023
Q4
$238K Buy
+32,588
New +$257K 0.01% 962
2023
Q2
Sell
-11,719
Closed -$146K 1533
2023
Q1
$146K Sell
11,719
-14,079
-55% -$259K 0.01% 989
2022
Q4
$496K Buy
25,798
+8,973
+53% +$190K 0.04% 573
2022
Q3
$315K Buy
+16,825
New +$346K 0.02% 733
2021
Q4
Sell
-932
Closed -$21K 1456
2021
Q3
$21K Buy
+932
New +$22.5K ﹤0.01% 1255

Other funds holding AHCO

Quantbot Technologies's AHCO Position: Q1 2026 in Review

Quantbot Technologies sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 9,860 shares — an estimated $98.2K sold.

Quantbot Technologies first reported a position in AHCO in Q3 2021 and held it in 8 quarters. The position peaked at $496K in Q4 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Quantbot Technologies reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 9,860 AdaptHealth shares in Q1 2026, an estimated $98.2K.
  • Quantbot Technologies first reported a position in AdaptHealth in Q3 2021 and held it in 8 quarters.
  • Quantbot Technologies's AdaptHealth position peaked at $496K in Q4 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.